# Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine

> **NCT03596918** · — · COMPLETED · sponsor: **AIDS Malignancy Consortium** · enrollment: 10 (actual)

## Conditions studied

- AIDS-Related Kaposi Sarcoma
- Human Immunodeficiency Virus 1 Positive

## Interventions

- **BIOLOGICAL:** Bleomycin Sulfate
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **DRUG:** Vincristine Sulfate

## Key facts

- **NCT ID:** NCT03596918
- **Lead sponsor:** AIDS Malignancy Consortium
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-10
- **Primary completion:** 2020-06-13
- **Final completion:** 2020-06-13
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-02-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03596918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03596918, "Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03596918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*